Your browser doesn't support javascript.
loading
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.
Hanania, Nicola A; Castro, Mario; Bateman, Eric; Pavord, Ian D; Papi, Alberto; FitzGerald, J Mark; Maspero, Jorge F; Katelaris, Constance H; Singh, Dave; Daizadeh, Nadia; Altincatal, Arman; Pandit-Abid, Nami; Soler, Xavier; Siddiqui, Shahid; Laws, Elizabeth; Jacob-Nara, Juby A; Rowe, Paul J; Lederer, David J; Hardin, Megan; Deniz, Yamo.
Afiliação
  • Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: hanania@bcm.edu.
  • Castro M; University of Kansas School of Medicine, Kansas City, Kansas.
  • Bateman E; University of Cape Town Lung Institute, Cape Town, South Africa.
  • Pavord ID; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Papi A; Respiratory Medicine Unit, University of Ferrara, S. Anna University Hospital, Ferrara, Italy.
  • FitzGerald JM; University of British Columbia, Vancouver, BC, Canada.
  • Maspero JF; Fundación CIDEA, Buenos Aires, Argentina.
  • Katelaris CH; Campbelltown Hospital, Campbelltown, NSW, Australia; Western Sydney University, Sydney, NSW, Australia.
  • Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University Foundation Trust NHS Hospital, Manchester, UK.
  • Daizadeh N; Sanofi, Cambridge, Massachusetts.
  • Altincatal A; Sanofi, Cambridge, Massachusetts.
  • Pandit-Abid N; Sanofi, Bridgewater, New Jersey.
  • Soler X; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Siddiqui S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Laws E; Sanofi, Bridgewater, New Jersey.
  • Jacob-Nara JA; Sanofi, Bridgewater, New Jersey.
  • Rowe PJ; Sanofi, Bridgewater, New Jersey.
  • Lederer DJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Hardin M; Sanofi, Cambridge, Massachusetts.
  • Deniz Y; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Ann Allergy Asthma Immunol ; 130(2): 206-214.e2, 2023 02.
Article em En | MEDLINE | ID: mdl-36332763

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article